Ballicules.com

Testosterone

ANDROGEL

What it isAndrogen-receptor agonist and principal endogenous androgen; replacement for hypogonadism.

Why this oneTopical gels and depot injections trade level stability against convenience and transfer risk.

What limits itIt suppresses spermatogenesis, so discuss fertility first; monitor hematocrit, and prevent skin transfer from gels.

FDA-approved for

FDA label

FDA dosingPopulationStartTargetMax
Hypogonadism (primary or hypogonadotropic) in adult menAdult men237 mg BID (morning and evening, with food)158–396 mg BID, titrated to serum testosterone396 mg BID

Renal Undefined

Hepatic Undefined

Instructions

Contraindications

Cautions

Adverse reactions

Pregnancy Contraindicated — teratogenic; may cause virilization of a female fetus

Lactation Not indicated for use in women

⚠ BOXED WARNINGS

Cost, est. cash$300–$5,000/dose or month

Generic entry2041 est.

Classes and tags

Clinical profile

Therapeutic safety burden2 / 4
Overdose danger2 / 4
Weight-gain liability0 / 4
Sedation liability0 / 4
QT / Torsades0 / 4
Direct muscarinic antagonism0 / 4
Embryofetal risk4 / 4

Legacy pregnancy categoryX

Defining liabilityErythrocytosis, infertility, hepatic/lipid effects and mood or misuse concerns.

Mechanism of action: Testosterone ballicule

Testosterone ballicule: receptor binding, kinetics and half-life diagram

Open Testosterone in the interactive console ↗

Memory aids: mascots and interaction avatars

Testosterone ANDROGEL mascot mnemonic cartoon
Testosterone mnemonic
Testosterone CYP3A4 substrate avatar
CYP3A4 substrate

Open Testosterone in the interactive console ↗